前线管理的地幔细胞淋巴瘤
Christine E Ryan1, Philippe Armand1, Ann S LaCasce1
1Division of Lymphoma, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Blood
|March 18, 2024
概括
膜细胞淋巴瘤 (MCL) 治疗进展的重点是改善第一次缓解的持续时间和耐受性. 新的策略探索向药物和优化化疗,以在这种无法治愈的癌症中获得更好的长期结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 临床研究 临床研究
背景情况:
- 膜细胞淋巴瘤 (MCL) 仍然在很大程度上无法治愈,尽管最近的治疗进展.
- 复发性/耐火性 (R/R) MCL 治疗的耐久性有限,强调需要改进前线 (1L) 策略.
- 最大限度地提高第一次缓解的持续时间对于MCL的长期良好结果至关重要.
研究的目的:
- 审查目前对1LMCL治疗的标准护理.
- 探索新的方法来推进1L MCL管理.
- 确定未来研究的关键领域,以治愈MCL.
主要方法:
- 审查现有关于标准护理MCL治疗的数据.
- 探索六个关键领域,以促进1L处理的进步.
- 突出正在进行的第3期试验,影响前线MCL管理.
主要成果:
- 目标代理正在从R/R转移到1L的MCL治疗.
- 优化化疗免疫疗法 (CIT) 骨干是一个重点领域.
- 新的策略包括将目标药物添加到CIT和省略CIT.
结论:
- 提高1L MCL治疗疗效和耐受性至关重要.
- 未来的方向包括有针对性的药物组合和可测量的残留疾病导向治疗.
- 目前正在进行的试验和进一步的调查对于实现治愈MCL至关重要.
更多相关视频
相关概念视频
Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


